(R)-4-Amino-3-fluoro-2-methyl-2-butanol, also known as AFMB, is a pharmaceutical compound that acts as an agonist for the α7 nicotinic acetylcholine receptor. It has been investigated for its potential use in the treatment of cognitive and neurodegenerative disorders, as well as schizophrenia.
Chemical Name: The chemical name for (R)-4-Amino-3-fluoro-2-methyl-2-butanol is (R)-4-amino-3-fluoro-2-methylbutan-2-ol.
Molecular Formula: The molecular formula for (R)-4-Amino-3-fluoro-2-methyl-2-butanol is C5H12FNO.
Formula Weight: The formula weight for (R)-4-Amino-3-fluoro-2-methyl-2-butanol is 119.15 g/mol.
CAS No: The CAS number for (R)-4-Amino-3-fluoro-2-methyl-2-butanol is 1544241-64-6.
Top Ten Keywords from Google and Synonyms:
Synonyms for (R)-4-Amino-3-fluoro-2-methyl-2-butanol include:
Health Benefits of This Product: (R)-4-Amino-3-fluoro-2-methyl-2-butanol has been studied for its potential use in treating cognitive and neurodegenerative disorders, as well as schizophrenia. Some studies suggest that it may improve brain function and enhance memory.
Potential Effects: (R)-4-Amino-3-fluoro-2-methyl-2-butanol works by binding to and activating the α7 nicotinic acetylcholine receptor, which is involved in a variety of physiological processes including learning and memory, attention, and inflammation. By targeting this receptor, (R)-4-Amino-3-fluoro-2-methyl-2-butanol has the potential to improve cognitive function and reduce inflammation in the brain.
Product Mechanism: (R)-4-Amino-3-fluoro-2-methyl-2-butanol acts as an agonist for the α7 nicotinic acetylcholine receptor, which is involved in regulating various physiological and pathological processes in the central nervous system (CNS). When activated, the α7 receptor stimulates the release of neurotransmitters such as dopamine, serotonin, and acetylcholine, which are important for cognitive function and other CNS processes.
Safety: The safety profile of (R)-4-Amino-3-fluoro-2-methyl-2-butanol is not well-established, as it is still in the early stages of research. However, initial studies have not reported any major safety concerns with the use of this compound.
Side Effects: There is limited information available on the potential side effects of (R)-4-Amino-3-fluoro-2-methyl-2-butanol. Further research will be needed to determine the safety and tolerability of this compound.
Dosing Information: The appropriate dosing for (R)-4-Amino-3-fluoro-2-methyl-2-butanol has not yet been established, as it is still in the early stages of development. Further research will be needed to determine the optimal dosing regimen for this compound.
Conclusion: (R)-4-Amino-3-fluoro-2-methyl-2-butanol is a pharmaceutical compound that acts as an agonist for the α7 nicotinic acetylcholine receptor. It has potential applications in the treatment of cognitive and neurodegenerative disorders, as well as schizophrenia. While initial studies have shown promise, more research will be needed to determine the safety, efficacy, and optimal dosing of this compound. As always, individuals should speak with their healthcare provider before starting any new medication or supplement.
